Reece Fulgham
Senior Operational and Restructuring Executive
Reece Fulgham
Senior Operational and Restructuring Executive
Senior Operational and Restructuring Executive
Senior Operational and Restructuring Executive
Reece Fulgham is a senior financial executive, former Kenneth Leventhal & Company CPA and turnaround specialist with over forty years of accounting, finance, operations, and turnaround experience. With a proven track record of leadership, he has worked with over fifty companies across a wide range of diverse industries. Mr. Fulgham focuses on leading companies through financial and operational restructurings, specializing in stabilizing organizations with limited liquidity by implementing urgent operational and financial restructurings. Reece’s leadership has spanned various roles, including Board Chairman, Assistant to the Chairman, Independent Director, Special Committee Member, CEO, CRO, CFO, and Vice President of Finance, with extensive experience in both domestic and international markets.
In addition, Reece has served as an Independent Director on twelve, mostly private equity turnaround middle-market company Boards of Directors, acting as Chairman for one, Audit Committee Chairman for ten, and Legal/Compliance Committee Member for four. He has been instrumental in approving multiple acquisitions and spin-offs, as well as facilitating the sale of seven companies and liquidation of three, and remains on two of these Boards. He has also served on multiple compensation, legal/compliance, investment and restructuring committees, where his insights have been instrumental in navigating complex financial situations.
Reece Fulgham has held key advisory roles across diverse industries, specializing in financial and operational reorganization and optimization, respectively. In his advisory capacity Mr. Fulgham has represented both debtors and lenders domestically and internationally.
Reece has served on a dozen Boards, often as Independent Director or Audit Committee Chairman, with a focus on private equity return and turnaround scenarios. Highlights include leading a $434 million sale as Chairman of LMG2 and driving EBITDA growth at Cornerstone Healthcare. His board work has consistently delivered strong returns, including a 30x equity gain at Trussway Manufacturing.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.